These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1901243)

  • 1. Five-hour balloon inflation to resolve recurrent reocclusion during coronary angioplasty.
    Brenner AS; Browne KF
    Cathet Cardiovasc Diagn; 1991 Feb; 22(2):107-11. PubMed ID: 1901243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator.
    Ellis SG; Topol EJ; George BS; Kereiakes DJ; Debowey D; Sigmon KN; Pickel A; Lee KL; Califf RM
    Circulation; 1989 Nov; 80(5):1159-65. PubMed ID: 2509102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute myocardial infarction: immediate coronary angioplasty for failure or contra-indications of thrombolytic therapy. Apropos of a series of 100 cases].
    Mossard JM; Arbogast R; Roman S; Baruthio J; Germain P; Roul G; Kraenner C; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):469-75. PubMed ID: 1905914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion.
    Becker RC
    Clin Cardiol; 1994 Jan; 17(1):3-13. PubMed ID: 8149679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction.
    Ward SR; Sutton JM; Pieper KS; Schwaiger M; Califf RM; Topol EJ
    Am J Cardiol; 1997 Mar; 79(5):539-44. PubMed ID: 9068505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
    Ross AM; Coyne KS; Reiner JS; Greenhouse SW; Fink C; Frey A; Moreyra E; Traboulsi M; Racine N; Riba AL; Thompson MA; Rohrbeck S; Lundergan CF
    J Am Coll Cardiol; 1999 Dec; 34(7):1954-62. PubMed ID: 10588209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome.
    Grines CL; Topol EJ; Bates ER; Juni JE; Walton JA; O'Neill WW
    Am Heart J; 1988 Jan; 115(1 Pt 1):1-7. PubMed ID: 2962478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ridogrel as an adjunct to thrombolysis in acute myocardial infarction.
    van der Wieken LR; Simoons ML; Laarman GJ; Van den Brand M; Nijssen KM; Dellborg M; Hermens W; Vrolik W
    Int J Cardiol; 1995 Nov; 52(2):125-34. PubMed ID: 8749872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency coronary angioplasty for acute myocardial infarction--factors affecting acute restenosis in catheterization laboratory and reocclusion during hospitalization.
    Kusachi S; Iwasaki K; Inoue K; Hina K; Nishiyama O; Kita T; Taniguchi G; Tsuji T
    Jpn Circ J; 1992 Sep; 56(9):871-80. PubMed ID: 1404842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
    Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
    J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of tissue plasminogen activator in the coronary care unit for acute closure after coronary angioplasty.
    Alzarka A; Haft JI; Goldstein JE
    Chest; 1990 May; 97(5):1241-2. PubMed ID: 2110053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
    J Am Coll Cardiol; 1995 Jul; 26(1):66-72. PubMed ID: 7797777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary coronary angioplasty for acute myocardial infarction with contraindication to thrombolysis.
    Himbert D; Juliard JM; Steg PG; Badaoui G; Baleynaud S; Le Guludec D; Aumont MC; Gourgon R
    Am J Cardiol; 1993 Feb; 71(5):377-81. PubMed ID: 8430622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.
    Topol EJ; Califf RM; Vandormael M; Grines CL; George BS; Sanz ML; Wall T; O'Brien M; Schwaiger M; Aguirre FV
    Circulation; 1992 Jun; 85(6):2090-9. PubMed ID: 1591828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty.
    Juliard JM; Himbert D; Cristofini P; Desportes JC; Magne M; Golmard JL; Aubry P; Benamer H; Boccara A; Karrillon GJ; Steg PG
    Am J Cardiol; 1999 Feb; 83(3):305-10. PubMed ID: 10072213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of right ventricular ischemia mimicking acute myocardial infarction during coronary angioplasty on the right coronary artery].
    Volponi MC; Raganelli L; Santoboni S; Di Ruzza G; Faticanti G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):193-5. PubMed ID: 17461362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between flow grade after thrombolytic therapy and the effect of angioplasty on left ventricular function: a prospective randomized trial.
    Belenkie I; Knudtson ML; Roth DL; Hansen JL; Traboulsi M; Hall CA; Manyari D; Filipchuck NG; Schnurr LP; Rosenal TW
    Am Heart J; 1991 Feb; 121(2 Pt 1):407-16. PubMed ID: 1990744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study.
    Ribichini F; Steffenino G; Dellavalle A; Ferrero V; Vado A; Feola M; Uslenghi E
    J Am Coll Cardiol; 1998 Nov; 32(6):1687-94. PubMed ID: 9822097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.